MX9906989A - Metodo para el tratamiento de enfermedades prostaticas empleando analogos activos de vitamina d. - Google Patents

Metodo para el tratamiento de enfermedades prostaticas empleando analogos activos de vitamina d.

Info

Publication number
MX9906989A
MX9906989A MXPA99006989A MX9906989A MX9906989A MX 9906989 A MX9906989 A MX 9906989A MX PA99006989 A MXPA99006989 A MX PA99006989A MX 9906989 A MX9906989 A MX 9906989A MX 9906989 A MX9906989 A MX 9906989A
Authority
MX
Mexico
Prior art keywords
active vitamin
analogues
treating prostatic
prostatic diseases
diseases
Prior art date
Application number
MXPA99006989A
Other languages
English (en)
Other versions
MXPA99006989A (es
Inventor
Richard B Mazess
Original Assignee
Bone Care Int Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bone Care Int Inc filed Critical Bone Care Int Inc
Publication of MX9906989A publication Critical patent/MX9906989A/es
Publication of MXPA99006989A publication Critical patent/MXPA99006989A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/16—Fluorine compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/22—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se presenta un metodo para el tratamiento de condiciones prostaticas como por ejemplo, cancer de Prostata e hiporplasia mediante la administracion de Lalia-hidroxiprevitamina D o bien vitamina D activadd o bien de una combinacion de los mismos en una forma de liberacion prolongada o bien en formulacion de liberacion retardada y prolongada. Tanto la forma de liberacion prolongada como la forma de liberacion retardada, prolongada incrementan los niveles sanguineos de vitamina D activa sin riesgo importante de hipercalcemia asociada con otras formas de administracion oral de vitamina D, para proporcionar el efecto benefico al tejido prostatico enfermo.
MXPA/A/1999/006989A 1996-12-30 1999-07-28 Metodo para el tratamiento de enfermedades prostaticas empleando analogos activos de vitamina d MXPA99006989A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08781910 1996-12-30
US08/781,910 US5763429A (en) 1993-09-10 1996-12-30 Method of treating prostatic diseases using active vitamin D analogues
PCT/US1997/022450 WO1998029123A1 (en) 1996-12-30 1997-12-10 Method of treating prostatic diseases using active vitamin d analogues

Publications (2)

Publication Number Publication Date
MX9906989A true MX9906989A (es) 2003-02-27
MXPA99006989A MXPA99006989A (es) 2003-10-20

Family

ID=

Also Published As

Publication number Publication date
CN1158081C (zh) 2004-07-21
JP2001511768A (ja) 2001-08-14
HUP0000558A3 (en) 2000-12-28
DE69737066D1 (de) 2007-01-18
CN1554351A (zh) 2004-12-15
CA2276606C (en) 2008-11-25
DE69737066T2 (de) 2007-06-21
WO1998029123A1 (en) 1998-07-09
ATE347366T1 (de) 2006-12-15
BR9713663A (pt) 2000-04-04
AU5595698A (en) 1998-07-31
HUP0000558A2 (hu) 2000-10-28
NZ336508A (en) 2001-08-31
KR20000062403A (ko) 2000-10-25
CN1248917A (zh) 2000-03-29
AU723835B2 (en) 2000-09-07
EP0948334A1 (en) 1999-10-13
US20040023934A1 (en) 2004-02-05
PL334393A1 (en) 2000-02-28
US5763429A (en) 1998-06-09
CA2276606A1 (en) 1998-07-09
EP0948334B1 (en) 2006-12-06
US6537982B1 (en) 2003-03-25

Similar Documents

Publication Publication Date Title
PL334393A1 (en) Method of treating prostate diseases using active vitamin d analogues
WO2006004918A3 (en) Method of treating prostatic diseases using a combination of vitamin d analogues and other agents
ATE319447T1 (de) Pharmazeutische zubereitungen die clavulansäure oder derivate enthalten zur behandlund von neurologischen störungen
IL127384A0 (en) Method of treating malignant tumors with thyroxine analogues having no significant hormonal activity
NZ336511A (en) Treating prostatic diseases using delayed and/or sustained release formulations of activated vitamin D
GEP20002146B (en) Therapeutic Peptide Derivatives
WO1993020203A3 (en) Stability-enhanced variants of parathyroid hormone
NO960445L (no) Hudplaster og fremgangsmåter for å administrere testosteron
ZA976562B (en) Isobutylgaba and its derivatives for the treatment of pain.
EP0702563A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER AND HYPERPROLIFERATIVE DISEASES
MY131805A (en) Synergistic composition and methods for treating neoplastic or cancerous growths and for restoring or boosting hematopoiesis.
AU1195499A (en) Thyroxine analogues having no significant hormonal activity to treat malignant tumors
PL323798A1 (en) Application of derivatives of vitamin d4 in treating skin diseases
ATE197670T1 (de) Parenterales busulfan zur behandlung von malignen krankheiten
ZA981609B (en) Method of treating a tumor
UA32457C2 (uk) Лікарський засіб (варіанти) і спосіб медикаментозного впливу на організм
AU9157901A (en) Methods of treating inflammatory and immune reactions and compositions therefor
DK0817646T3 (da) Fremgangsmåder til behandling af inflammation og præparater derfor
AU9369098A (en) Therapeutic method
GR3037047T3 (en) Combination therapy for advanced cancer comprising temozolomide and cisplatin
UA10053A (uk) Спосіб лікування невиношування вагітності
MX9603833A (es) Tratamiento mejorado del cancer con temozolomida.
WO2003072737A3 (en) Biological inhibitions induced by contact inhibitory factor
UA43728A (uk) Спосіб лікування раку передміхурової залози
UA30125A (uk) Спосіб лікування дітей з ревматоїдним артритом та дифузними хворобами сполучної тканини

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees